Aptorum Group LTD
Market Movers (8-K)
NASDAQ
Niki BioSolutions, Inc. (formerly Aptorum Group Limited) and DiamiR Biosciences Corp. have completed their merger, establishing a new entity focused on biopharmaceutical and diagnostics.
Schedule 13D - Activist Investments
NASDAQ
Kira S. Sheinerman has filed a Schedule 13D, reporting beneficial ownership of 1,515,293 shares, or 51.56%, of Niki BioSolutions, Inc. common stock, acquired as merger consideration.
Schedule 13G - Passive Investments
NASDAQ
L1 Capital Global Opportunities Master Fund, Ltd. has filed an amended Schedule 13G indicating a complete divestment of its Class A Ordinary Shares in Aptorum Group Ltd, reducing its beneficial ownership to 0%.
Worse than expected
NASDAQ
SCHEDULE 13G: Scoggin Entities File Schedule 13G for Aptorum Group, Disclosing No Beneficial Ownership
A group of Scoggin entities and individuals filed a Schedule 13G for Aptorum Group Limited, confirming they hold no beneficial ownership in the company's Class A Ordinary Shares.
NASDAQ
L1 Capital Global Opportunities Master Fund, Ltd. has reported a 7.2% beneficial ownership stake in Aptorum Group Ltd's Class A Ordinary Shares.